Prevalence of systemic lupus erythematosus in Colombia: data from the national health registry 2012–2016
Introduction Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides...
Saved in:
Published in | Lupus Vol. 28; no. 10; pp. 1273 - 1278 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.09.2019
Sage Publications Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 0961-2033 1477-0962 1477-0962 |
DOI | 10.1177/0961203319864168 |
Cover
Abstract | Introduction
Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis.
Objectives
We used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016.
Methods
This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case.
Results
National records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45–49-year age group.
Conclusions
This is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries. |
---|---|
AbstractList | Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis.
We used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016.
This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case.
National records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45-49-year age group.
This is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries. Introduction Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis. Objectives We used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016. Methods This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case. Results National records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45–49-year age group. Conclusions This is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries. Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis.INTRODUCTIONRegistries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis.We used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016.OBJECTIVESWe used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016.This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case.METHODSThis is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case.National records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45-49-year age group.RESULTSNational records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45-49-year age group.This is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries.CONCLUSIONSThis is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries. IntroductionRegistries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis.ObjectivesWe used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016.MethodsThis is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case.ResultsNational records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45–49-year age group.ConclusionsThis is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries. |
Author | Rincón-Riaño, D N Fernández-Ávila, D G Gutiérrez Dávila, J M Bernal-Macías, S Rosselli, D |
Author_xml | – sequence: 1 givenname: D G surname: Fernández-Ávila fullname: Fernández-Ávila, D G – sequence: 2 givenname: S orcidid: 0000-0002-7010-8338 surname: Bernal-Macías fullname: Bernal-Macías, S – sequence: 3 givenname: D N surname: Rincón-Riaño fullname: Rincón-Riaño, D N – sequence: 4 givenname: J M surname: Gutiérrez Dávila fullname: Gutiérrez Dávila, J M – sequence: 5 givenname: D surname: Rosselli fullname: Rosselli, D |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31354025$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1q3DAQx0VIaHbT3HMqgl56cTOSbNnurSz5KASSQ3o2Wnmc1SJbW0kO7C3vkDfsk0TOJi0stJcZZub3H-ZjTg4HNyAhZwy-MlaW51BLxkEIVlcyZ7I6IDOWl2WW8vyQzKZyNtWPyTyENQAkUn4gx4KJIgdezMj6zuOjsjhopK6jYRsi9kZTO27GQNFv4wp7FV1IkRnowlnXL436RlsVFe2862ki6KCicYOydIXKxhX1-GBC9FvKgfHfT8_JyY_kqFM24OmbPyE_Ly_uF9fZze3Vj8X3m0wLWcRM60IVAG0Fy2TT8F2hUIq8KrFseaGlWLIub0UNrE57MymEqKAQIJSQDHJxQr7s-m68-zViiE1vgkZr1YBuDA3nMmlynlcJ_byHrt3o0x4TVYGoa8anhp_eqHHZY9tsvOmV3zbvV0wA7ADtXQgeuz8Ig2Z6VLP_qCSRexJt4usRo1fG_k-Y7YRBPeDfcf_JvwBpLp__ |
CitedBy_id | crossref_primary_10_1016_j_rcreu_2021_06_008 crossref_primary_10_1371_journal_pone_0273324 crossref_primary_10_1016_j_acci_2023_07_003 crossref_primary_10_1016_j_clicom_2023_10_002 crossref_primary_10_1016_j_msard_2023_104915 crossref_primary_10_1080_24725625_2021_1909213 crossref_primary_10_1016_j_reuma_2024_09_005 crossref_primary_10_1016_j_rcreu_2024_06_002 crossref_primary_10_7759_cureus_42053 crossref_primary_10_1016_j_vhri_2021_04_005 crossref_primary_10_1371_journal_pone_0285889 crossref_primary_10_1155_crin_5285961 crossref_primary_10_1016_j_rcreu_2021_10_004 crossref_primary_10_1038_s41584_021_00668_1 crossref_primary_10_1080_14656566_2025_2464913 crossref_primary_10_1016_j_rcreu_2021_05_008 crossref_primary_10_1038_s41598_024_72564_z crossref_primary_10_1007_s11657_024_01412_4 crossref_primary_10_1080_13696998_2024_2316536 crossref_primary_10_1177_0961203319878498 crossref_primary_10_1016_j_rcreu_2021_03_003 crossref_primary_10_1177_09612033231184315 crossref_primary_10_1016_j_reumae_2024_09_006 crossref_primary_10_1016_j_rcreue_2021_05_001 crossref_primary_10_1007_s00296_022_05183_4 crossref_primary_10_1016_j_jtauto_2021_100133 crossref_primary_10_1016_j_reumae_2024_11_003 crossref_primary_10_1016_j_rcreue_2021_07_004 crossref_primary_10_1016_j_rcreue_2021_10_010 crossref_primary_10_4081_reumatismo_2023_1568 crossref_primary_10_1016_j_rcreu_2021_05_018 crossref_primary_10_1016_j_rcreu_2021_02_009 crossref_primary_10_1016_j_rcreue_2023_07_003 crossref_primary_10_1097_MD_0000000000019797 crossref_primary_10_1016_j_rcreu_2024_02_006 crossref_primary_10_1055_s_0041_1733844 crossref_primary_10_3390_ijerph17041315 crossref_primary_10_1016_j_reuma_2024_06_006 crossref_primary_10_1016_j_rcreu_2021_07_001 crossref_primary_10_1016_j_rcreue_2021_02_005 |
Cites_doi | 10.1177/0961203310374305 10.1053/berh.2002.0259 10.1016/j.autrev.2013.12.002 10.1016/S1568-9972(03)00006-5 10.1016/j.rdc.2009.12.005 10.1097/BOR.0000000000000198 10.1093/rheumatology/32.2.110 10.1080/1744666X.2017.1327352 10.1016/0002-9343(91)90151-M 10.1002/art.38238 10.2165/11598550-000000000-00000 10.1177/0961203313512881 10.1177/0961203311412096 10.1002/art.1780380914 10.1002/acr.20683 10.1002/art.1780380415 10.1136/lupus-2014-000021 10.1177/0961203309106831 10.1093/rheumatology/37.5.491 10.1159/000381424 10.1186/ar2368 10.1016/S0140-6736(07)60279-7 10.1136/annrheumdis-2018-213512 |
ContentType | Journal Article |
Copyright | The Author(s) 2019 |
Copyright_xml | – notice: The Author(s) 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 |
DOI | 10.1177/0961203319864168 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1477-0962 |
EndPage | 1278 |
ExternalDocumentID | 31354025 10_1177_0961203319864168 10.1177_0961203319864168 |
Genre | Journal Article |
GeographicLocations | Colombia |
GeographicLocations_xml | – name: Colombia |
GroupedDBID | --- -TM .2E .2F .2G .2J .2N .GJ 01A 0R~ 18M 1~K 29L 31R 31S 31U 31X 31Y 31Z 36B 39C 4.4 53G 54M 5GY 5VS 7X7 88E 8FI 8FJ 8R4 8R5 AABMB AABOD AACKU AACMV AACTG AADUE AAEWN AAGGD AAGLT AAGMC AAJIQ AAJOX AAJPV AAKGS AANSI AAPEO AAQDB AAQXH AAQXI AARDL AARIX AATAA AATBZ AAUAS AAXOT AAYTG AAZBJ ABAFQ ABAWP ABCCA ABCJG ABDBF ABDWY ABEIX ABFWQ ABHKI ABHQH ABIDT ABJIS ABJZC ABKRH ABLUO ABOCM ABPGX ABPNF ABQKF ABQXT ABRHV ABUJY ABUWG ABVFX ABVVC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACFYK ACGBL ACGFO ACGFS ACGZU ACJER ACJTF ACLFY ACLHI ACLZU ACOFE ACOXC ACPRK ACROE ACRPL ACSIQ ACUAV ACUHS ACUIR ACXKE ACXMB ADBBV ADDLC ADEBD ADEIA ADMPF ADNBR ADNMO ADNON ADRRZ ADSTG ADTBJ ADUCT ADUKL ADVBO ADYCS ADZZY AECGH AECVZ AEDTQ AEGXH AEKYL AENEX AEPTA AEQLS AERKM AESZF AEUHG AEWDL AEWHI AEXFG AEXNY AFEET AFKBI AFKRA AFKRG AFMOU AFOSN AFQAA AFUIA AFWMB AGHKR AGKLV AGNHF AGPXR AGQPQ AGWFA AGWNL AHDMH AHMBA AIAGR AIGRN AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ ALIPV ALKWR ALMA_UNASSIGNED_HOLDINGS AMCVQ ANDLU ARTOV ASPBG AUTPY AUVAJ AVWKF AYAKG AZFZN AZQEC B3H B8M B8O B8R B8Z B93 B94 BBRGL BDDNI BENPR BKIIM BKNYI BKSCU BPACV BPHCQ BSEHC BVXVI BWJAD BYIEH C45 CBRKF CCPQU CDWPY CFDXU CORYS CQQTX CS3 CUTAK DB0 DC- DC0 DD- DD0 DE- DF0 DO- DOPDO DU5 DV7 DV9 D~Y EAD EAP EBC EBD EBS EJD EMB EMK EMOBN EPL ESX F5P FEDTE FHBDP FYUFA GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HMCUK HVGLF HZ~ J8X K.F K.J K9- M0R M1P N9A O9- OVD P.B P2P PHGZM PHGZT PQQKQ PROAC PSQYO Q1R Q2X Q7K Q7L Q7R Q7U Q7X Q82 Q83 ROL S01 SASJQ SAUOL SCNPE SDB SFB SFC SFK SFN SFT SGA SGO SGP SGR SGV SGX SGZ SHG SNB SPJ SPQ SPV SQCSI STM SV3 TEORI TUS UKHRP ZONMY ZPPRI ZRKOI ZSSAH AAYXX AJGYC CITATION ALTZF CGR CUY CVF ECM EIF M4V NPM 7T5 AAPII AJVBE H94 K9. 7X8 AJHME |
ID | FETCH-LOGICAL-c365t-cc5a500d80b00d033f5ae63487e7d25c63b1f4d3901919816333805303a361043 |
ISSN | 0961-2033 1477-0962 |
IngestDate | Fri Sep 05 08:49:16 EDT 2025 Fri Jul 25 02:58:10 EDT 2025 Thu Apr 03 07:04:09 EDT 2025 Thu Apr 24 22:50:22 EDT 2025 Tue Jul 01 05:22:55 EDT 2025 Tue Jun 17 22:45:31 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Colombia systemic lupus erythematosus registries Latin America |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c365t-cc5a500d80b00d033f5ae63487e7d25c63b1f4d3901919816333805303a361043 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-7010-8338 |
PMID | 31354025 |
PQID | 2280399124 |
PQPubID | 32637 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2266334248 proquest_journals_2280399124 pubmed_primary_31354025 crossref_primary_10_1177_0961203319864168 crossref_citationtrail_10_1177_0961203319864168 sage_journals_10_1177_0961203319864168 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20190900 2019-09-00 2019-Sep 20190901 |
PublicationDateYYYYMMDD | 2019-09-01 |
PublicationDate_xml | – month: 9 year: 2019 text: 20190900 |
PublicationDecade | 2010 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: England – name: London |
PublicationTitle | Lupus |
PublicationTitleAlternate | Lupus |
PublicationYear | 2019 |
Publisher | SAGE Publications Sage Publications Ltd |
Publisher_xml | – name: SAGE Publications – name: Sage Publications Ltd |
References | Farooqi, Gibson 1998; 37 Pons-Estel, Bonfa, Soriano 2018; 77 Osio-Salido, Manapat-Reyes 2010; 19 Calixto, Anaya 2014; 13 Lim, Drenkard 2015; 27 Pons-Estel, Ugarte-Gil, Alarcón 2017; 13 D’Cruz, Khamashta, Hughes 2007; 369 Pineles, Valente, Warren, Peterson, Lehman, Moorthy 2011; 20 Vasudevan, Krishnamurthy 2010; 36 Méndez-Ayala, Nariño, Rosselli 2015; 44 Jakes, Bae, Louthrenoo, Mok, Navarra, Kwon 2012; 64 Petri, Perez-Gutthann, Longenecker, Hochberg 1991; 91 Somers, Marder, Cagnoli 2014; 66 Nasonov, Soloviev, Davidson 2014; 23 Scolnik, Marin, Valeiras 2014; 1 Ståhl-Hallengren, Jönsen, Nived, Sturfelt 2000; 27 McCarty, Manzi, Medsger TA, Ramsey-Goldman, Laporte, Kwoh 1995; 38 Petri 2002; 16 Zeng, Chen, Darmawan 2008; 10 Arnaud, Mathian, Boddaert, Amoura 2012; 29 Cooper, Stroehla 2003; 2 Cervera, Khamashta, Hughes 2009; 18 bibr5-0961203319864168 bibr22-0961203319864168 bibr1-0961203319864168 bibr18-0961203319864168 bibr14-0961203319864168 bibr9-0961203319864168 bibr27-0961203319864168 bibr10-0961203319864168 bibr15-0961203319864168 bibr23-0961203319864168 bibr2-0961203319864168 Ståhl-Hallengren C (bibr20-0961203319864168) 2000; 27 bibr19-0961203319864168 bibr24-0961203319864168 bibr6-0961203319864168 bibr11-0961203319864168 bibr28-0961203319864168 bibr16-0961203319864168 bibr25-0961203319864168 bibr3-0961203319864168 bibr12-0961203319864168 bibr7-0961203319864168 bibr4-0961203319864168 bibr21-0961203319864168 bibr17-0961203319864168 bibr26-0961203319864168 bibr8-0961203319864168 bibr13-0961203319864168 31581893 - Lupus. 2019 Nov;28(13):1610-1611 |
References_xml | – volume: 64 start-page: 159 year: 2012 end-page: 168 article-title: Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality publication-title: Arthritis Care Res (Hoboken) – volume: 1 start-page: e000021 year: 2014 end-page: e000021 article-title: Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study publication-title: Lupus Sci Med – volume: 10 start-page: R17 year: 2008 end-page: R17 article-title: Rheumatic diseases in China publication-title: Arthritis Res Ther – volume: 38 start-page: 1260 year: 1995 end-page: 1270 article-title: Incidence of systemic lupus erythematosus. Race and gender differences publication-title: Arthritis Rheum – volume: 37 start-page: 491 year: 1998 end-page: 495 article-title: Prevalence of the major rheumatic disorders in the adult population of north Pakistan publication-title: Br J Rheumatol – volume: 27 start-page: 685 year: 2000 end-page: 691 article-title: Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis publication-title: J Rheumatol – volume: 19 start-page: 1365 year: 2010 end-page: 1373 article-title: Epidemiology of systemic lupus erythematosus in Asia publication-title: Lupus – volume: 13 start-page: 799 year: 2017 end-page: 814 article-title: Epidemiology of systemic lupus erythematosus publication-title: Expert Rev Clin Immunol – volume: 91 start-page: 345 year: 1991 end-page: 353 article-title: Morbidity of systemic lupus erythematosus: role of race and socioeconomic status publication-title: Am J Med – volume: 23 start-page: 213 year: 2014 end-page: 219 article-title: The prevalence and incidence of systemic lupus erythematosus (SLE) in selected cities from three Commonwealth of Independent States countries (the Russian Federation, Ukraine and Kazakhstan) publication-title: Lupus – volume: 29 start-page: 181 year: 2012 end-page: 189 article-title: Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment publication-title: Drugs Aging – volume: 13 start-page: 641 year: 2014 end-page: 654 article-title: Socioeconomic status. The relationship with health and autoimmune diseases publication-title: Autoimmun Rev – volume: 20 start-page: 1187 year: 2011 end-page: 1192 article-title: Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus publication-title: Lupus – volume: 77 start-page: 1549 year: 2018 end-page: 1557 article-title: First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR) publication-title: Ann Rheum Dis – volume: 16 start-page: 847 year: 2002 end-page: 858 article-title: Epidemiology of systemic lupus erythematosus publication-title: Best Pract Res Clin Rheumatol – volume: 18 start-page: 869 year: 2009 end-page: 874 article-title: The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe publication-title: Lupus – volume: 369 start-page: 587 year: 2007 end-page: 596 article-title: Systemic lupus erythematosus publication-title: Lancet – volume: 36 start-page: 1 year: 2010 end-page: 13 article-title: Changing worldwide epidemiology of systemic lupus erythematosus publication-title: Rheum Dis Clin North Am – volume: 27 start-page: 427 year: 2015 end-page: 432 article-title: Epidemiology of lupus: an update publication-title: Curr Opin Rheumatol – volume: 2 start-page: 119 year: 2003 end-page: 125 article-title: The epidemiology of autoimmune diseases publication-title: Autoimmun Rev – volume: 44 start-page: 144 year: 2015 end-page: 148 article-title: Burden of epilepsy in Colombia publication-title: Neuroepidemiology – volume: 66 start-page: 369 year: 2014 end-page: 378 article-title: Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program publication-title: Arthritis Rheumatol – ident: bibr15-0961203319864168 doi: 10.1177/0961203310374305 – ident: bibr3-0961203319864168 – ident: bibr14-0961203319864168 doi: 10.1053/berh.2002.0259 – ident: bibr12-0961203319864168 doi: 10.1016/j.autrev.2013.12.002 – ident: bibr2-0961203319864168 doi: 10.1016/S1568-9972(03)00006-5 – ident: bibr5-0961203319864168 – ident: bibr1-0961203319864168 doi: 10.1016/j.rdc.2009.12.005 – ident: bibr22-0961203319864168 doi: 10.1097/BOR.0000000000000198 – ident: bibr27-0961203319864168 doi: 10.1093/rheumatology/32.2.110 – ident: bibr10-0961203319864168 – ident: bibr9-0961203319864168 doi: 10.1080/1744666X.2017.1327352 – ident: bibr13-0961203319864168 doi: 10.1016/0002-9343(91)90151-M – ident: bibr16-0961203319864168 doi: 10.1002/art.38238 – ident: bibr24-0961203319864168 doi: 10.2165/11598550-000000000-00000 – ident: bibr21-0961203319864168 doi: 10.1177/0961203313512881 – ident: bibr28-0961203319864168 doi: 10.1177/0961203311412096 – ident: bibr23-0961203319864168 doi: 10.1002/art.1780380914 – volume: 27 start-page: 685 year: 2000 ident: bibr20-0961203319864168 publication-title: J Rheumatol – ident: bibr17-0961203319864168 doi: 10.1002/acr.20683 – ident: bibr26-0961203319864168 doi: 10.1002/art.1780380415 – ident: bibr8-0961203319864168 doi: 10.1136/lupus-2014-000021 – ident: bibr25-0961203319864168 doi: 10.1177/0961203309106831 – ident: bibr18-0961203319864168 doi: 10.1093/rheumatology/37.5.491 – ident: bibr6-0961203319864168 doi: 10.1159/000381424 – ident: bibr19-0961203319864168 doi: 10.1186/ar2368 – ident: bibr11-0961203319864168 doi: 10.1016/S0140-6736(07)60279-7 – ident: bibr4-0961203319864168 – ident: bibr7-0961203319864168 doi: 10.1136/annrheumdis-2018-213512 – reference: 31581893 - Lupus. 2019 Nov;28(13):1610-1611 |
SSID | ssj0003196 |
Score | 2.4271345 |
Snippet | Introduction
Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian... Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of... IntroductionRegistries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian... |
SourceID | proquest pubmed crossref sage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1273 |
SubjectTerms | Adolescent Adult Age Distribution Aged Aged, 80 and over Child Child, Preschool Colombia - epidemiology Diagnosis Epidemiology Female Humans Infant Lupus Lupus Erythematosus, Systemic - diagnosis Lupus Erythematosus, Systemic - epidemiology Male Middle Aged Prevalence Registries Sex Distribution Systemic lupus erythematosus Young Adult |
Title | Prevalence of systemic lupus erythematosus in Colombia: data from the national health registry 2012–2016 |
URI | https://journals.sagepub.com/doi/full/10.1177/0961203319864168 https://www.ncbi.nlm.nih.gov/pubmed/31354025 https://www.proquest.com/docview/2280399124 https://www.proquest.com/docview/2266334248 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLZKJyFuEP8UBjISQkJRttjOX7lbKWOaGBfTJu2uShxHylSSqW2Q2BXvwEvxHDwJ59iJk5YNMW4iJ3HtJOfr8fH5JeR1nvE8C2TswuKuXD-G1hi6uj7wvjzlCRZdRW-Lz-HBqX94FpwNBj97Xkv1Kt2Rl1fGlfwPVeEa0BWjZG9AWTsoXIA20BeOQGE4_hONMf9SoqOGUOYzSZkL6czri3rpqMU3k5G1WtZLE9w3r76khS7Gg46hXWiJ1QiaqEgHqzVgETgH1m3eukMIOAn7suwnnKavj9ZGd4ZKaRebMftazI05qavgNdE5p92jROreUxNPZiXS46LUNyaidI_hUbHJKjOGNRp9hE9qDPyLhbp0pmbedrLDRsHbqDJY56tldZIhAwKbzBg7ynBkP4qg3zrL5nEfml6PATMeid5iDqfx1QuFNlXjhDgfwyT1zNT3Wc_JvbFWWg9G1qZJ3xjhFtniEUhxQ7K1N5lO9q1UgKxO531sXrEzme9ujrEuIv2x71nzOdRi0Mk9crfZv9A9A8b7ZKDKB-T2UeOh8ZCcd5ikVU5bTFKNSbqGSVqUtMXkO4qIpIhICj1oi0hqEElbRFJE5K_vPxCLj8jp_oeT9wduU8_DlSIMVq6UAdbfyGIPeH0GL5wHiQoFbJlVlPFAhiJluZ-hFm4M3wJ2CkLEsEh4IhEg5fviMRmWVameEhr6KuZpEHk8hy13ko2jzJNY-SHzmPSVGpHd9hPOZJPsHmuuzGfXEW5E3tpfXJhEL3_pu91SZdawg-UM80qBtA_y8oi8sreBWaMFLilVVWMfgIbwuQ9DPDHUtJMJhipYHozIGyRvN_B1T_HsBk_8nNzp_nDbZLha1OoFSNOr9GUD1N8hv7VM |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+systemic+lupus+erythematosus+in+Colombia%3A+data+from+the+national+health+registry+2012%E2%80%932016&rft.jtitle=Lupus&rft.au=Fern%C3%A1ndez-%C3%81vila%2C+D+G&rft.au=Bernal-Mac%C3%ADas%2C+S&rft.au=Rinc%C3%B3n-Ria%C3%B1o%2C+D+N&rft.au=Guti%C3%A9rrez+D%C3%A1vila%2C+J+M&rft.date=2019-09-01&rft.issn=0961-2033&rft.eissn=1477-0962&rft.volume=28&rft.issue=10&rft.spage=1273&rft.epage=1278&rft_id=info:doi/10.1177%2F0961203319864168&rft.externalDBID=n%2Fa&rft.externalDocID=10_1177_0961203319864168 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0961-2033&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0961-2033&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0961-2033&client=summon |